Press release
Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market to Register Unwavering Growth During 2025
The report on the exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market analyzes the current and future scenario of the global market. Rise in the prevalence of cystic fibrosis and chronic pancreatitis, and increase in prevalence of diabetes across the world are the major drivers of the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market.
Report overview @ https://www.xploremr.com/report/567/exocrine-pancreatic-insufficiency-epi-therapeutics-and-diagnostics-market
The exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market with respect to the segments based on therapeutics & diagnostics types, and geography.
A detailed qualitative analysis of drivers and restraints of the market and its opportunities have been provided in the market overview section. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market.
Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market: Segmentation
Based on type, the exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market is segmented as therapeutics & diagnostics. The diagnostics segment is again sub-segmented into blood tests, endoscopic ultra-sonography, magnetic resonance imaging [MRI], and CT scanning.
The market size and forecast, in terms of value, for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.
Geographically, the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market has been categorized into five major regions and the key countries in the respective regions: North America (the U.S., Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries, and Rest of Middle East & Africa).
The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The country wise market size and analysis for each segment in terms of value has been provided in the report. The research study also covers the competitive scenario in these regions.
Get a free sample request @ https://www.xploremr.com/connectus/sample/567
Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market: Competitive Dynamics
The report also profiles major players in the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments.
Major players profiled in this report include – Abbvie, Inc., Allergan plc, Nordmark Arzneimittel GmbH & Co. KG, Digestive Care, Inc., Janssen Pharmaceuticals, Inc., Cilian AG, Anthera Pharmaceuticals, Inc., AzurRx Biopharma, Inc. and others.
The global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market is segmented as given below:
Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market, by Type
Therapeutics
Diagnostics
Blood Tests
Endoscopic Ultra-sonography (EUS)
Magnetic Resonance Imaging (MRI)
CT Scanning
Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics & Diagnostics Market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Spain
Rest of Europe
Asia Pacific
Japan
India
China
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC countries
South Africa
Rest of Middle East & Africa
Buy Now Full Report @ https://www.xploremr.com/cart/reports/buynow/567
About Us
XploreMR is one of the world’s leading resellers of high-quality market research reports. We feature in-depth reports from some of the world’s most reputed market research companies and international organizations. We serve across a broad spectrum – from Fortune 500 to small and medium businesses. Our clients trust us for our unwavering focus onquality and affordability. We believe high price should not be a bottleneck for organizations looking to gain access to quality information.
Contact Us
XploreMR
111 North Market Street, Suite 300
San Jose, CA 95113, United States
Tel: +1-669-284-0108
Email: sales@xploremr.com
Website: https://www.xploremr.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market to Register Unwavering Growth During 2025 here
News-ID: 1075407 • Views: …
More Releases from Xplore Market Research
Anti-counterfeit Pharmaceutical Packaging Market Pegged for Robust Expansion Dur …
This report by Future Market Insights on the global anti-counterfeit pharmaceutical packaging market for the period 2016–2026 presents an outlook of the market across the globe. The primary objective of the report is to offer updates on market opportunities in the global anti-counterfeit pharmaceutical packaging market.
Report overview @ https://www.xploremr.com/report/1028/anti-counterfeit-pharmaceutical-packaging-market
The report is categorically divided into three sections namely, by usage features, by technology and by region, to understand and offer…
Pallets Market to Reflect Impressive Growth Rate During 2024
Persistence Market Research analyzes the India Pallets market over an eight year period from 2016 to 2024. The study demonstrates market dynamics and trends across regions that are expected to influence the current status and future prospects of the India Pallets market over the forecast period (2016 - 2024).
Report overview @ https://www.xploremr.com/report/977/india-pallets-market
The primary objective of the report is to offer information on market drivers, restraints, trends, opportunities, and value…
Water Softening Systems Market Set to Witness an Uptick during 2015 to 2025
This report by XploreMR on the ‘Global Water Softening Systems Market’ for the period 2015 - 2025 presents an outlook of the water softening systems market across the globe. The primary objective of the report is to offer updates on the market opportunities in the global water softening systems market.
Report overview @ https://www.xploremr.com/report/920/water-softening-systems-market
The report provides value (US$ Mn) and volume (units) analysis of the global water softening systems market across…
Military Defense Vehicle Intercom System Market to Witness Increase in Revenues …
Fact.MR Report examines global Military Defense Vehicle Intercom System for the forecast period 2017–2027. The prime purpose of the report is to find opportunities and trends in the market and provide insights pertaining to segments of the military defense vehicle intercom systems market.
To understand trends and opportunities in military defense vehicle intercom system market, the report is divided into various segments on the basis of intercom type, transmission power type,…
More Releases for EPI
Consumer Electronics Adoption Fuels The Silicon Epi Wafer Market: Core Growth En …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Will the Silicon EPI Wafer Industry Market Size Be by 2025?
Over recent years, the market size for silicon EPI wafers has seen considerable growth. Predictions indicate an increase from $1.8 billion in 2024 to $1.92 billion in 2025, representing a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this historical…
Evolving Market Trends In The Silicon EPI Wafer Industry: Next-Generation Silico …
The Silicon EPI Wafer Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Silicon EPI Wafer Market Size During the Forecast Period?
In recent times, the silicon EPI wafer market has witnessed substantial growth. The market size, which stood at $1.8 billion in…
Leading Growth Driver in the Silicon EPI Wafer Market in 2025: Consumer Electron …
What industry-specific factors are fueling the growth of the silicon epi wafer market?
The silicon EPI wafer market is expected to experience significant growth due to the increased use of consumer electronics products. Consumer electronics (CE) refers to electronic devices specifically designed for everyday use by consumers for non-commercial or professional purposes. Silicon wafers, which are semiconductors, are used in the manufacture of microchips and chips for these electronic devices. For…
EPI Invests $1 Million USD in the EPI Data Center Futurist Scholarship Program
Singapore (15 June 2023) - EPI, the global leader in data center training, audit & certification, is proud to announce the launch of the EPI Data Center Futurist Scholarship program, accompanied by a significant investment of one (1) million US-Dollar. This transformative initiative aims to provide aspiring professionals with the resources and support they need to acquire the specialized knowledge and skills necessary for success in the dynamic data…
Epi Wafer Market to Surpass Valuation of US$ 5.8 Bn by 2030 with Rising Demand f …
The global Epi Wafer market is estimated to attain a valuation of US$ 5.8 billion by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 6% during the forecast period, 2021-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of…
Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease.
Download the sample report at: https://www.pharmaproff.com/request-sample/1024
Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI…
